Table 5.
Haplogroup distribution in controls and patients with HTN (cohorts 1, 2, and 3).
| Parsed haplogroup | Haplogroup | Controls (total %) | HTN (total %) | Total (total %) |
|---|---|---|---|---|
| D5 | D5 | 94 (9.68) | 47 (4.84) | 141 (14.52) |
| F4 | F4 | 14 (1.44) | 18 (1.85) | 32 (3.30) |
| N9a | N9a | 33 (3.40) | 27 (2.78) | 60 (6.18) |
| Macro-M | D | 56 (5.77) | 43 (4.43) | 99 (10.20) |
| E | 8 (0.82) | 3 (0.31) | 11 (1.13) | |
| G | 11 (1.13) | 7 (0.72) | 18 (1.85) | |
| M* | 25 (2.57) | 8 (0.82) | 33 (3.40) | |
| M10 | 9 (0.93) | 6 (0.62) | 15 (1.54) | |
| M7 | 72 (7.42) | 43 (4.43) | 115 (11.84) | |
| M8 | 42 (4.33) | 20 (2.06) | 62 (6.39) | |
| M9 | 11 (1.13) | 5 (0.51) | 16 (1.65) | |
| Macro-N | A | 25 (2.57) | 12 (1.24) | 37 (3.81) |
| B | 115 (11.84) | 55 (5.66) | 170 (17.51) | |
| F | 94 (9.68) | 44 (4.53) | 138 (14.21) | |
| R | 18 (1.85) | 6 (0.62) | 24 (2.47) | |
| Total | 627 (64.57) | 344 (35.43) | 971 | |